Short communication · 29 Nov 2025
Conference abstractPublished 23 Nov 2012
Regulatory affairs for pharmaceuticals
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The current Pharmaceutical Industry is well organized, systematic and compliant to international regulatory standards for manufacturing of Chemical and Biological drugs for human and veterinary consumption as well as medical devices, traditional herbal products and cosmetics. Stringent GMPs are being followed for blood and its derivative as well as controlled manufacturing for Traditional Herbal Medicines, Cosmetics, Food and Dietary products which was otherwise differently a century before. Each regulatory system had faced certain circumstances which led to current well-defined controlled regulatory framework. This has resulted into systematic manufacturing and marketing of safe, efficacious and qualitative drugs. With the growth of industry, the legislations from each region have become more and more complex and created a need for regulatory professionals. I propose to cover below aspects in my presentation: 1) Evolution of regulatory framework in USA, EU and India and major regulations 2) Brief regulatory environment of Emerging Markets i.e. Brazil, Russia, Mexico, South Africa, Thailand and GCC 3) Drug Regulatory Affairs and Global, Regional and National Regulatory Network 4) Key Organizations for Harmonization of regulatory requirements i.e. WHO and ICH 5) Regional Regulatory Network and its regulations i.e. GCC, ASEAN, APEC, PANDARH, SADC, EU 6) Roles of Regulatory Affairs Professional in Health Authorities as well as Pharmaceutical Industry 7) Regulatory Affairs Network in Pharmaceutical Industry Above presentation would provide global insight of regulatory framework to all participants.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 29 Jan 2025
The role of regulatory affairs in pharmaceutics: Ensuring drug safety and compliance.
Brief report · 30 Nov 2024
The Impact of Digital Transformation on Pharmaceutical Regulatory Affairs
Conference abstract · 23 Sep 2024
Regulatory Affairs: Dependence and Overview in the Pharmaceutical Industry by Cdsco
Article · 3 Jan 2024
Regulatory Affairs: Key Considerations for Global Pharmaceutical Markets
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hasumati Rahalkar”

